Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Inventory: 2018-2025

Historic Change in Inventory for Sunshine Biopharma (SBFM) over the last 7 years, with Sep 2025 value amounting to $1.3 million.

  • Sunshine Biopharma's Change in Inventory rose 2.66% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 21.16%. This contributed to the annual value of $6.0 million for FY2024, which is 153.93% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Change in Inventory stood at $1.3 million, which was up 131.71% from $555,075 recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Change in Inventory peaked at $2.1 million during Q1 2024, and registered a low of -$206,974 during Q4 2022.
  • Over the past 3 years, Sunshine Biopharma's median Change in Inventory value was $848,847 (recorded in 2024), while the average stood at $980,226.
  • The largest annual percentage gain for Sunshine Biopharma's Change in Inventory in the last 5 years was 2,456.77% (2022), contrasted with its biggest fall of 702.72% (2022).
  • Sunshine Biopharma's Change in Inventory (Quarterly) stood at $34,340 in 2021, then slumped by 702.72% to -$206,974 in 2022, then soared by 652.94% to $1.1 million in 2023, then skyrocketed by 57.71% to $1.8 million in 2024, then increased by 2.66% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $555,075 for Q2 2025, and $568,834 during Q1 2025.